1.Meta-analysis of the efficacy and safety of apatinib combined with PD-1/PD-L1 inhibitors in the treatment of malignant solid tumors
Chen WANG ; Jun LI ; Ning WANG ; Xinjuan YU ; Xiaolu YU ; Tingtian LI
China Pharmacy 2025;36(16):2067-2072
OBJECTIVE To evaluate the efficacy and safety of apatinib combined with PD-1/PD-L1 inhibitors in the treatment of malignant solid tumors. METHODS Randomized controlled trials (RCTs) on apatinib combined with PD-1/PD-L1 inhibitors (combination group) versus monotherapy (apatinib or PD-1/PD-L1)combined with (or) chemotherapy/other treatments (control group) in the treatment of malignant solid tumors were collected from PubMed, Web of Science, Embase, Cochrane Library, CNKI, VIP, Wanfang Data and China Biomedical Literature Database. The search time limit was from the establishment of the databases to May 2025. After literature screening, data extraction and literature quality evaluation, meta-analysis was performed using RevMan 5.3 and Stata 14.0. RESULTS A total of 28 RCTs involving 2 974 patients were included. The objective response rate [RR=1.639, 95%CI(1.452,1.851), P<0.000 01], disease control rate [RR=1.284, 95%CI(1.178,1.399), P<0.000 01] and CD3+, CD4+, CD4+/CD8+ as well as the incidence of ADR such as hypertension, fatigue, proteinuria, thrombocytopenia were significantly higher in the combination group than control group (P<0.05 or P<0.000 01). The progressive disease rate [RR= 0.497, 95%CI(0.437, 0.566), P<0.000 01] and serum tumor + marker levels and CD8 were significantly lower in the combination group than control group (P<0.05 or P<0.000 01). Subgroup analysis results of different types of tumors showed that the objective response rate and disease control rate were significantly higher in the combination group than control group (P<0.05). The results of sensitivity analysis showed that the stability of this study was good. The results of publication bias analysis showed that there was a high possibility of publication bias in this study. CONCLUSIONS Apatinib combined with PD-1/ PD-L1 inhibitors has a significant efficacy in the treatment of different types of tumors, but attention should be paid to the occurrence of hypertension, fatigue, proteinuria and thrombocytopenia.
2.Study on the establishment of quality control system of TaiChi accelerator on the basis of AAPM TG119 reporter
Tingtian PANG ; Tao WANG ; Qiqi LEI ; Bo YANG ; Zhiqun WANG ; Jie ZHANG ; Yinzhu CHEN ; Shihao LI ; Peng ZAN ; Jie QIU
China Medical Equipment 2024;21(6):1-5,11
Objective:The purpose of this study is to test and assess the model of modeling data of TaiChi accelerator in the Raystation Treatment Planning System(RayStation system)according to the test method and item of TG119 report of American Association Physicians Medicine(AAPM).Methods:The intensity-modulated radiation therapy(IMRT)and volumetric-modulated arc therapy(VMAT)plans of the test cases of different clinical situations,which included the simulated multi target region,prostate target region,head and neck target region,easy type C-shape target region plan and difficult type C-shape target region plan,were designed according to the AAPM TG119 report in the treatment planning system.The deviations of the doses of point and area of the two kinds of plans were measured,and the measured results were compared and analyzed with the recommended standards of AAPM TG119 report.The IBA CC13 ionization chamber and the ArcCHECK matrix ionization chamber were used respectively to verify the point dose and area dose,and the assessment standard was γ passing rate under 3%3mm.The confidence interval was adopted to judge the consistency between the measured dose and the calculated dose.Results:The accuracies of plan dose target,point dose deviation and area dose distribution of tested cases could meet the requirement of the TGl19 report.The deviations of mean doses for the high-dose points of IMRT plan and VMAT plan of tested cases were respectively(0.39±1.02)%and(1.27±0.64)%,and the confidence intervals of them were respectively 2.39%and 2.52%.The average dose deviations of low doses of organ at risk(OAR)of IMRT plan and VMAT plan were respectively(0.53±1.73)%and(0.88±1.11)%,and the confidence intervals were respectively 3.92%and 3.06%.The average γ passing rate under 3%/3mm of IMRT plan and VMAT plan were respectively(99.52±0.366)%and(99.86±0.136)%,and the confidence intervals of them were respectively 1.196%and 0.406%.Conclusion:The TaiChi accelerator performance and the accuracy of Raystation system 6MV FFF model fitting can meet the standard of TG119 report,and the subsequent standards of the quality control of equipment and patients were established according to these tested results,which would provide reference for the improvement of the performance of subsequent accelerator.
3.Quality control of source positioning and timer accuracy for high - dose rate afterloading machine
Lang YU ; Bo YANG ; Xia LIU ; Tingtian PANG ; Nan LIU ; Wenbo LI ; Tingting DONG ; Bei WANG ; Zhiqun WANG ; Jie QIU
Chinese Journal of Radiation Oncology 2018;27(6):598-600
Objective To explore and establish accurate detection quality control method of source positioning and timer precision for afterloading equipment. Methods The source positioning detection device was made of hd camera,EBT3 disposable film and steel rule,collecting source in each resident point for video images and film. Accurate measurement of radioactive source positioning and timer accuracy, including the timing absolute error and linear error through analysis of image sampling rate. After the film grayscale distribution analysis,comparison between film gray peak position and the measurement of resident point geometry,got the stay point source physics and radiation center deviation. Results Radioactive source physics and radiation center deviation was (-0.33± 0. 10) mm;For all default dwell time,timer average absolute deviation was (0.22±0. 02) s,linear fitting result was y=x-0. 226,R2=1,timing linear error was-0. 01% Conclusions established detection means through the video images and film exposure quantitative analysis for accurately determination of source positioning,dwell time and source radiation center precision. After experimental testing the machine precision satisfied the requirement of clinical use.
4.A comparative study of measurement of small field data and calculation based on Monte Carlo method
Ning CHEN ; Jianliang ZHOU ; Jie QIU ; Bo YANG ; Tingtian PANG ; Nan LIU ; Xia LIU ; Lang YU ; Wenbo LI ; Tingting DONG ; Fuquan ZHANG
Chinese Journal of Radiation Oncology 2017;26(9):1077-1079
Objective To compare the relative dose of small fields measured by clinically common detectors and those obtained from Monte Carlo simulation in order to obtain the accurate measurement method, and to modify the inappropriate detectors.Methods The percentage depth-dose distribution curve and profile (flatness and symmetry) curves were collected at 2 cm×2 cm, 3 cm×3 cm, and 4 cm×4 cm under 6-MV X-ray of Trilogy linear accelerator by CC13, PFD, SFD, and blue phantom.The results were compared with the stimulation results from Monte Carlo method (the current gold standard).The correction factors for the detectors with large error were calculated to provide reference data for clinical practice.Results The results measured by SFD detector were most close to the results from Monte Carlo simulation.The measurement errors of CC13 and PFD detectors were large.The correction factor in the penumbra for CC13 and PFD detector was 0.664-1.499.Conclusions SFD detector is better than CC13 and PFD detector in the measurement of small fields, but CC13 and PFD detector can provide reference data for clinical practice after the corresponding correction.
5.Peripheral dosimetry of a Trilogy accelerator
Bo YANG ; Tingtian PANG ; Xiansong SUN ; Tingting DONG ; Chunli LUO ; Guanqun WANG ; Hongming LI ; Ke HU ; Jie QIU ; Fuquan ZHANG
Chinese Journal of Radiation Oncology 2016;25(10):1108-1112
Objective To determine the peripheral dose ( PD) of a Trilogy accelerator under different conditions and the feasibility of PD measurement using the semiconductor diode ionization chamber. Methods In a solid water phantom, a CC13 air?filled ionization chamber and a semiconductor diode ionization chamber were used for PD measurements with different distances (13 measurement locations within 1?31 cm) , depth ( 3, 5, 15 cm) , field sizes ( 10, 20, 30 cm) , wedge ( W15, W45, VW15, VW45) , and beam energy (6, 18 MV). The relationship of PD with PDleakage and PDscat er was determined by removing the scatter phantom. Simulating the patients with cervical cancer undergoing radiotherapy, a CIRS phantom received volumetric modulated arc therapy ( VMAT) , step?shoot intensity?modulated radiotherapy ( IMRT) , and sliding?window IMRT to measure PDs of the breast, thyroid, and lens. All the data were normalized to the isocenter. Results PD was gradually reduced with the increase in distance ( 13?41% at 1 cm from the edge to 0?25% at 31 cm from the edge) . With a fixed distance from the edge of the radiation field, there was no significant difference in PD between different depths. A radiation field with a size of 30 cm had a PD about two?fold higher than that with a size of 10 cm. PD increased with the increase in the physical wedge angle and increased by 1% compared with the open field;PD decreased with the increase in the virtual wedge angle and decreased by 2?3% compared with the open field. PD decayed from 13?35% at 1 cm to 0?23% at 31 cm under 6 MV X?ray and from 11?06% at 1 cm to 0?20% at 31 cm under 18 MV X?ray. Dscat er was dominant in the regions close to the edge of radiation field and decreased from 62?45% at 1 cm to 5?71% at 25 cm. In all measurements under 6 MV X?ray, the maximum proportion difference between CC13 ionization chamber and diode ionization chamber was less than 1%. PDs of the breast, thyroid, and lens were 6?72, 2?90, and 2?37 mGy in VMAT mode, 7?39, 4?05, and 2?48 mGy in step?shoot IMRT mode, and 9?17, 4?61, and 3?21 mGy in sliding?window IMRT mode, respectively. Conclusions For the measurement of PDs, the CC13 air?filled ionization chamber and semiconductor diode ionization chamber have good consistency and feasibility under 6 MV X?ray. In clinical practice, the understanding of the relationship of PD with different radiation conditions helps to reduce the doses to organs at risk. Shielding and protective techniques can further reduce dose deposition.
6.A daily quality assure procedure for the on board imager and analysis of the results
Qiu GUAN ; Nan LI ; Nan LIU ; Tingtian PANG ; Jie QIU ; Fuquan ZHANG
Chinese Journal of Radiation Oncology 2012;(6):560-562
Objective Performing a daily quality assure (QA) program to get variation and error range of on board imager (OBI) system,so that the OBI system can meet the needs of clinical treatment.Methods The daily QA program including: mechanical accuracy,2D/2D Shift calculations accuracy,couch motion accuracy.Results The max deviation was-0.7 mm in lcft-right (LR) dircction and 0.8 mm in superior-inferior (S1) direction in Linac& OBI isocenter accuracy check.The max deviations in 4 blades (x1,x2,y2,y1) position accuracy check were:-2.1 mm,2.2 mm,± 1.7 mm,-2.1 mm.In OBI mechanical arms position accuracy check,31% standard data was 85.2 cm with 0 mm deviation; 69% standard data was 85.1 cm with 1 mm deviation.In LR,SI and anterior-posterior direction,2D/2D shift calculations accuracy was 0.46 mm,1.35 mm,-0.04 mm and couch motion accuracy was-0.1 mm,0.3 mm,0.2 mm,respectively.Conclusions By performing the daily QA program,it could be found whether OBI works properly and satisfies the clinical use.The physicist can pay more attention to the parameters which change frequently,and adjust the frequency of the parameters which are stable,so that working efficiently.

Result Analysis
Print
Save
E-mail